Finally, we report the development of a gene therapy approach that alleviates neurodegenerative phenotypes and prolongs lifespan in the INAD mice providing potential therapeutic strategies to treat INAD and PARK14. The gene discussed is PLA2G6; the disease is neurodegeneration with brain iron accumulation 2A.